Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effect of prednisone on platelet function tests.

K A Jørgensen, L Freund, P Sørensen

    Scandinavian Journal of Haematology
    |February 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Limits on Light Dark Matter Interactions in a Low Threshold Two-Channel Athermal Phonon Detector from the TESSERACT Collaboration.

    Physical review letters·2025
    Same author

    First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

    Physical review letters·2025
    Same author

    New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

    Physical review letters·2025
    Same author

    Dark Matter Search Results from 4.2  Tonne-Years of Exposure of the LUX-ZEPLIN (LZ) Experiment.

    Physical review letters·2025
    Same author

    Erratum: Measurement of the Sixth-Order Cumulant of Net-Proton Multiplicity Distributions in Au+Au Collisions at sqrt[s_{NN}]=27, 54.4, and 200 GeV at RHIC [Phys. Rev. Lett. 127, 262301 (2021)].

    Physical review letters·2025
    Same author

    Erratum: Nonmonotonic Energy Dependence of Net-Proton Number Fluctuations [Phys. Rev. Lett. 126, 092301 (2021)].

    Physical review letters·2025
    Same journal

    Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).

    Scandinavian journal of haematology·1986
    Same journal

    The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.

    Scandinavian journal of haematology·1986
    Same journal

    RES phagocytosis in children with homozygous beta-thalassemia in relation to blood transfusion.

    Scandinavian journal of haematology·1986
    Same journal

    Two allotypes of factor IX present in haemophilia B.

    Scandinavian journal of haematology·1986
    Same journal

    Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients.

    Scandinavian journal of haematology·1986
    Same journal

    Prognostic significance of a morphometric study of lymph node biopsies in chronic lymphocytic leukaemia.

    Scandinavian journal of haematology·1986
    See all related articles

    Prednisone treatment did not alter platelet function in patients with collagen or hematological diseases. However, platelet counts significantly increased after six weeks of prednisone use.

    Area of Science:

    • Hematology
    • Pharmacology
    • Immunology

    Background:

    • Prednisone is a common corticosteroid used in treating collagen and hematological diseases.
    • Platelet function is crucial in hemostasis and can be affected by various medical conditions and treatments.

    Purpose of the Study:

    • To investigate the effects of prednisone on platelet function in patients with collagen or hematological diseases.
    • To assess changes in bleeding time, capillary fragility, platelet aggregation, and adhesion.

    Main Methods:

    • Evaluated 22 patients with collagen or hematological diseases undergoing prednisone treatment.
    • Measured Ivy bleeding time, capillary fragility, and platelet aggregation (threshold ADP concentration).
    • Assessed platelet adhesiveness and platelet counts at 2 days and 6 weeks.

    Related Experiment Videos

    Main Results:

    • No significant changes were observed in Ivy bleeding time, capillary fragility, platelet aggregation, or adhesion after 2 days or 6 weeks of prednisone.
    • Platelet counts remained unchanged after 2 days but showed a significant increase after 6 weeks of treatment.
    • Prednisone did not significantly impact key platelet function parameters.

    Conclusions:

    • Short-term and moderate-term prednisone treatment (up to 6 weeks) does not significantly impair platelet function in patients with collagen or hematological diseases.
    • The observed increase in platelet counts after 6 weeks warrants further investigation.
    • Clinicians can be reassured regarding platelet function during standard prednisone therapy in this patient group.